These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10233390)

  • 1. High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma.
    Rasmussen T; Kastrup J; Knudsen LM; Johnsen HE
    Br J Haematol; 1999 Apr; 105(1):265-7. PubMed ID: 10233390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
    Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients.
    Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E
    Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tumor specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients by a PCR-SSCP method.
    Wu S; Wang L; Wang Y; Zhu P; Xie G
    Chin Med J (Engl); 1997 Sep; 110(9):682-5. PubMed ID: 9642324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment.
    Rasmussen T; Jensen L; Johnsen HE
    Leuk Lymphoma; 2002 May; 43(5):1075-7. PubMed ID: 12148889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
    Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
    Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and kinetics of polyclonal and clonal B cells in the peripheral blood of patients being treated for multiple myeloma.
    Rasmussen T; Jensen L; Honoré L; Johnsen HE
    Blood; 2000 Dec; 96(13):4357-9. PubMed ID: 11110713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma.
    Levy Y; Schmitt C; Tsapis A; Brouet JC; Fermand JP
    Clin Exp Immunol; 1991 Jun; 84(3):435-9. PubMed ID: 2044222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation.
    Patriarca F; Gaidano G; Capello D; Zaja F; Fanin R; Baccarani M
    Haematologica; 2000 Sep; 85(9):982-5. PubMed ID: 10980639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis.
    Manske MK; Zuckerman NS; Timm MM; Maiden S; Edelman H; Shahaf G; Barak M; Dispenzieri A; Gertz MA; Mehr R; Abraham RS
    Clin Immunol; 2006 Jul; 120(1):106-20. PubMed ID: 16515886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays.
    Rasmussen T; Jensen L; Honoré L; Andersen H; Johnsen HE
    Br J Haematol; 1999 Dec; 107(4):818-24. PubMed ID: 10606890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells.
    Rasmussen T; Hansson L; Osterborg A; Johnsen HE; Mellstedt H
    Blood; 2003 Jun; 101(11):4607-10. PubMed ID: 12576327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone.
    Taylor BJ; Pittman JA; Seeberger K; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2002 Feb; 8(2):502-13. PubMed ID: 11839670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.
    Hansen A; Gosemann M; Pruss A; Reiter K; Ruzickova S; Lipsky PE; Dörner T
    Arthritis Rheum; 2004 Jun; 50(6):1897-908. PubMed ID: 15188366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.
    Kay NE; Leong T; Kyle RA; Greipp P; Billadeau D; Van Ness B; Bone N; Oken MM
    Blood; 1997 Jul; 90(1):340-5. PubMed ID: 9207470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma.
    Yu SC; Chen SU; Lu W; Liu TY; Lin CW
    Histopathology; 2011 May; 58(6):896-905. PubMed ID: 21401705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
    Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.